Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common
-
Shares outstanding
-
22.2M
-
Number of holders
-
444
-
Total 13F shares, excl. options
-
18.8M
-
Shares change
-
-458K
-
Total reported value, excl. options
-
$6.16B
-
Value change
-
-$152M
-
Put/Call ratio
-
0.73
-
Number of buys
-
200
-
Number of sells
-
-196
-
Price
-
$328.51
Significant Holders of BIO-RAD LABORATORIES, INC. - Common (BIO) as of Q4 2024
507 filings reported holding BIO - BIO-RAD LABORATORIES, INC. - Common as of Q4 2024.
BIO-RAD LABORATORIES, INC. - Common (BIO) has 444 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.8M shares
of 22.2M outstanding shares and own 84.61% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (2.01M shares), VANGUARD GROUP INC (1.92M shares), Veritas Asset Management LLP (977K shares), DIMENSIONAL FUND ADVISORS LP (746K shares), VAN ECK ASSOCIATES CORP (723K shares), First Eagle Investment Management, LLC (714K shares), STATE STREET CORP (690K shares), EARNEST PARTNERS LLC (618K shares), ARIEL INVESTMENTS, LLC (561K shares), and Select Equity Group, L.P. (461K shares).
This table shows the top 444 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.